Pulmonary disease during immunosuppressive therapy
Clarysse, A.M.
Therapeutische Umschau. Revue Therapeutique 28(11): 724-730
1971
ISSN/ISBN: 0040-5930 PMID: 5151793 Document Number: 41865
Document emailed within 1 workday
Related Documents
Nyerges, G.; Mészner, Z.; Gyarmati, E.; Kerpel-Fronius, S. 1987: Acyclovir in the therapy of varicella zoster-caused disease in children undergoing immunosuppressive therapy Orvosi Hetilap 128(40): 2083-2088Lewczuk, J.; Piszko, P.; Jagas, J.; Wrabec, K. 2005: Impact of 30 day therapy with doxazosin--alpha1 adrenergic blocker on pulmonary hemodynamics in patients with secondary pulmonary hypertension due to chronic obstructive pulmonary disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(105): 279-281
Rimon, D.; Lahat, N.; Nir, E.; Cohen, L. 1985: Behçet's disease: clinical and immunological response to immunosuppressive therapy. A case report Israel Journal of Medical Sciences 21(1): 57-61
Olivari, M.T.; Homans, D.C.; Wilson, R.F.; Kubo, S.H.; Ring, W.S. 1989: Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy Circulation 80(5 Part 2): Iii111-5
Schoeman, M.N.; Liddle, C.; Bilous, M.; Grierson, J.; Craig, P.I.; Batey, R.G.; Farrell, G.C. 1990: Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression Australian and New Zealand Journal of Medicine 20(1): 56-62
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Ishii, T.; Matsuse, T. 1999: Recent progress on the therapy for chronic obstructive pulmonary disease (COPD)--usefulness and practice of the step-by-step pharmacologic therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 57(9): 2035-2040
Aswapokee, P.; Aswapokee, N.; Chirawong, P.; Leelarasamee, A. 1977: Pulmonary nocardiosis in a patient receiving immunosuppressive agent Southeast Asian Journal of Tropical Medicine and Public Health 8(3): 317-321
Kamińska, M.; Piotrowicz, E.; Ratajczak, B.; Boj, E. 1973: Treatment of idiopathic pulmonary hemosiderosis with immunosuppressive agents Pediatria Polska 48(6): 765-769
Kino, H. 2003: New drug therapy of chronic obstructive pulmonary disease Nihon Rinsho. Japanese Journal of Clinical Medicine 61(12): 2175-2180
Criep, L.H. 1973: Corticoid therapy in chronic obstructive pulmonary disease Geriatrics 28(1): 111-115
Martí, V.; Moya, C.; Fontcuberta, J.; Obrador, D. 1991: Pulmonary thromboembolism during cyclosporin immunosuppressive treatment in a heart transplant patient Medicina Clinica 96(5): 197
Demikhova, O.V.; Degtiareva, S.A. 2001: New aspects of combined therapy of chronic pulmonary heart disease Problemy Tuberkuleza 7: 40-42
Verdich, J.; Christensen, A.L. 1979: Pulmonary disease complicating intermittent methotrexate therapy of psoriasis Acta Dermato-Venereologica 59(5): 471-473
Hartman, R.B. 1979: Pulmonary heart disease: pathophysiology, diagnostic signs, and therapy Postgraduate Medicine 66(3): 58-63 66-9 71
Selitskaia, R.P.; Solov'eva, I.P.; Zotova, L.A. 1978: Effect of immunosuppressive agents on the immunity organs during development of destructive pulmonary tuberculosis Problemy Tuberkuleza 8: 56-63
Berzins, G.F. 1970: An occupational therapy program for the chronic obstructive pulmonary disease patient American Journal of Occupational Therapy: Official Publication of the American Occupational Therapy Association 24(3): 181-186
Sroczyński, J.; Podolecki, A.; Koczwara, A.; Biskupek, K.; Burak, W.; Schneiberg, P. 1990: Long-term oxygen therapy of chronic pulmonary heart disease Pneumonologia Polska 58(1): 8-11
Borukaeva, I.K. 2009: Effectiveness of hypoxic therapy in patients with chronic obstructive pulmonary disease Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2: 16-18
Hanson, C.W.; Marshall, B.E.; Frasch, H.F.; Marshall, C. 1996: Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease Critical Care Medicine 24(1): 23-28